MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.lungcan.2017.08.021

Медицинская библиотека · Lung cancer (Amsterdam, Netherlands) · 2017

EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.

Han Baohui, Tjulandin Sergei, Hagiwara Koichi, Normanno Nicola, Wulandari Laksmi, Laktionov Konstantin, Hudoyo Achmad, He Yong, Zhang Yi-Ping, Wang Meng-Zhao, Liu Chien Ying, Ratcliffe Marianne, McCormack Rose, Reck Martin

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

Limited understanding exists of epidermal growth factor receptor (EGFR) mutation frequency in less common subgroups of advanced non-small-cell lung cancer (aNSCLC) (e.g. squamous cell carcinoma [SCC]), and to what extent local practices exclude patients from EGFR testing based on their clinical characteristics.

MATERIALS AND

METHODS

IGNITE (non-comparative/-interventional; NCT01788163) was conducted in 90 centres (Asia-Pacific/Russia). Eligible patients: local/metastatic aNSCLC; chemotherapy-naïve, newly-diagnosed/recurrent disease after resection; ineligible for curative treatment. Patients provided a tissue/cytology (all) and a blood plasma (China/Russia/South Korea/Taiwan) sample. Primary endpoint: EGFR mutation frequency in aNSCLC patients (adenocarcinoma [ADC]/non-ADC), as per local practices.

RESULTS

3382 patients were enrolled. EGFR mutation frequencies for evaluable tissue/cytology samples in Asia-Pacific and Russian patients: 49.3% (862/1749) and 18.0% (90/500) for ADC tumours; 14.1% (74/525) and 3.7% (15/402) for non-ADC; 9.9% (40/403) and 3.7% (13/349) for SCC. Of Russian patients with SCC tumours harbouring common, activating EGFR mutations, 6/9 were never-/former-smokers. Mutation status concordance between 2581 matched tissue/cytology and plasma samples: 80.5% (sensitivity 46.9%, specificity 95.6%).

CONCLUSION

EGFR mutation testing should be considered in all Asian aNSCLC patients. Also, as activating EGFR mutations were observed in a small number of Caucasian squamous NSCLC patients, testing here may be appropriate, particularly in those with no/remote smoking history. Circulating free tumour-derived DNA is feasible for mutation analysis employing well-validated and sensitive methods, when tumour samples are unavailable.

Для цитирования: Han Baohui, Tjulandin Sergei, Hagiwara Koichi, Normanno Nicola, Wulandari Laksmi, Laktionov Konstantin, Hudoyo Achmad, He Yong, Zhang Yi-Ping, Wang Meng-Zhao, Liu Chien Ying, Ratcliffe Marianne, McCormack Rose, Reck Martin. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.. Lung cancer (Amsterdam, Netherlands). 2017. DOI: 10.1016/j.lungcan.2017.08.021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.